1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11
(Synonyms: 15(S)-HETE-SAPE-d11, 15(S)-Hydroxyeicosatetraenoic Acid-SAPE-d11, 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-Phosphatidylethanolamine-d11) 目录号 : GC49730An internal standard for the quantification of 1-stearoyl-2-15(S)-HETE-sn-glycero-3-PE
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 is intended for use as an internal standard for the quantification of 1-stearoyl-2-15(S)-HETE-sn-glycero-3-PE by GC- or LC-MS. 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE is a phospholipid that contains stearic acid at the sn-1 position and 15(S)-HETE at the sn-2 position. It is formed in human peripheral monocytes activated by the calcium ionophore A23187 by direct oxidation of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PE by 15-lipoxygenase (15-LO).1,2 Phosphoethanolamine (PE) HETEs (PE-HETEs), including 1-stearoyl-2-15(S)-HETE-sn-glycero-3-PE, are the main source of esterified HETE in ionophore-activated monocytes.
1.Maskrey, B.H., BermÚdez-Fajardo, A., Morgan, A.H., et al.Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenaseJ. Biol. Chem.282(28)20151-20163(2007) 2.Morgan, A.H., Hammond, V.J., Morgan, L., et al.Quantitative assays for esterified oxylipins generated by immune cellsNat. Protoc.5(12)1919-1931(2010)
Cas No. | N/A | SDF | Download SDF |
别名 | 15(S)-HETE-SAPE-d11, 15(S)-Hydroxyeicosatetraenoic Acid-SAPE-d11, 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-Phosphatidylethanolamine-d11 | ||
Canonical SMILES | OP(OC[C@H](OC(CCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)COC(CCCCCCCCCCCCCCCCC)=O)(OCCN)=O | ||
分子式 | C43H67D11NO9P | 分子量 | 795.1 |
溶解度 | Ethanol: 1 mg/ml | 储存条件 | -80°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.2577 mL | 6.2885 mL | 12.577 mL |
5 mM | 0.2515 mL | 1.2577 mL | 2.5154 mL |
10 mM | 0.1258 mL | 0.6289 mL | 1.2577 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。